Yousong Ding

3.1k total citations · 1 hit paper
76 papers, 2.3k citations indexed

About

Yousong Ding is a scholar working on Molecular Biology, Pharmacology and Biotechnology. According to data from OpenAlex, Yousong Ding has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 29 papers in Pharmacology and 18 papers in Biotechnology. Recurrent topics in Yousong Ding's work include Microbial Natural Products and Biosynthesis (28 papers), Marine Sponges and Natural Products (11 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Yousong Ding is often cited by papers focused on Microbial Natural Products and Biosynthesis (28 papers), Marine Sponges and Natural Products (11 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Yousong Ding collaborates with scholars based in United States, China and Singapore. Yousong Ding's co-authors include David H. Sherman, Steven D. Bruner, Ke Ding, York Tomita, Jeanne A. Stuckey, Yipin Lu, Krzysztof Krajewski, Peter P. Roller, Su Qiu and Damon A. Parrish and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Yousong Ding

68 papers receiving 2.3k citations

Hit Papers

Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yousong Ding United States 27 1.1k 735 717 311 269 76 2.3k
Masayoshi Arai Japan 29 1.5k 1.4× 642 0.9× 905 1.3× 633 2.0× 135 0.5× 132 3.3k
Zhongjun Ma China 28 1.2k 1.1× 304 0.4× 563 0.8× 298 1.0× 71 0.3× 136 2.2k
Sangku Lee South Korea 28 845 0.8× 758 1.0× 311 0.4× 148 0.5× 105 0.4× 101 2.0k
Shigehiro Takase Japan 23 1.1k 1.0× 883 1.2× 640 0.9× 337 1.1× 74 0.3× 89 2.1k
Zhili Zuo China 25 796 0.7× 378 0.5× 460 0.6× 107 0.3× 78 0.3× 101 1.8k
Michael Greenstein United States 30 1.1k 1.0× 916 1.2× 1.3k 1.8× 745 2.4× 75 0.3× 77 2.6k
Xu Shen China 31 1.6k 1.5× 392 0.5× 214 0.3× 147 0.5× 76 0.3× 66 2.3k
Hidetoshi Yamada Japan 27 1.3k 1.2× 1.4k 1.9× 248 0.3× 227 0.7× 65 0.2× 153 2.4k
Jiangnan Peng United States 27 1.1k 1.0× 1.7k 2.3× 538 0.8× 716 2.3× 45 0.2× 96 3.2k
Eric Débiton France 25 855 0.8× 555 0.8× 213 0.3× 104 0.3× 106 0.4× 51 1.9k

Countries citing papers authored by Yousong Ding

Since Specialization
Citations

This map shows the geographic impact of Yousong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yousong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yousong Ding more than expected).

Fields of papers citing papers by Yousong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yousong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yousong Ding. The network helps show where Yousong Ding may publish in the future.

Co-authorship network of co-authors of Yousong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yousong Ding. A scholar is included among the top collaborators of Yousong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yousong Ding. Yousong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yousong, et al.. (2025). Biocatalytic potential of microbial CYP450s in the degradation of selected environmental pollutants. Medicinal Chemistry Research. 34(11). 2228–2238.
2.
Dhakal, Dipesh, et al.. (2025). Synthetic biology strategies for cyanobacterial systems to heterologously produce cyanobacterial natural products. Natural Product Reports. 42(8). 1240–1250. 3 indexed citations
3.
Liu, Dake, Zhixin Wang, Gilles J. Basset, et al.. (2025). Tomato pollen tube growth requires flavonol glycosylation. PLANT PHYSIOLOGY. 199(3).
4.
Philmus, Benjamin, Nicole E. Avalon, Yousong Ding, et al.. (2025). Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery. Natural Product Reports. 43(2). 286–300. 1 indexed citations
5.
Liu, Jie, Steven D. Bruner, Yousong Ding, et al.. (2025). Structure Determination and Biosynthesis of Dapalides A–C, Glycosylated Kahalalide F Analogues from the Marine Cyanobacterium Dapis sp. Journal of Natural Products. 88(9). 2138–2150.
6.
Huang, Jia‐Qi, Yousong Ding, & Zhiping Zheng. (2025). Triply chalcogenophenolato-bridged erbium-cyclooctatetraenyl complexes: syntheses and single-molecule magnetic properties. Inorganic Chemistry Frontiers. 12(24). 8560–8571.
7.
Seabra, Gustavo, et al.. (2024). Characterization of a Dual Function Peptide Cyclase in Graspetide Biosynthesis. ACS Chemical Biology. 19(12). 2525–2534. 1 indexed citations
8.
Kallifidas, Dimitris, Dipesh Dhakal, Man‐Yun Chen, et al.. (2024). Biosynthesis of Dolastatin 10 in Marine Cyanobacteria, a Prototype for Multiple Approved Cancer Drugs. Organic Letters. 26(7). 1321–1325. 12 indexed citations
9.
Brevi, Arianna, Joanna Zhang, Abhinav Bhushan, et al.. (2024). Engineered bacterial therapeutics for detecting and treating CRC. Trends in cancer. 10(7). 588–597. 3 indexed citations
10.
Liu, Ke, et al.. (2023). Design, synthesis and evaluation of halogenated phenazine antibacterial prodrugs targeting nitroreductase enzymes for activation. RSC Medicinal Chemistry. 14(8). 1472–1481. 7 indexed citations
11.
Pan, Li, et al.. (2023). Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 28(2). 677–677. 5 indexed citations
12.
Ushijima, Blake, Sarath P. Gunasekera, Julie L. Meyer, et al.. (2023). Chemical and genomic characterization of a potential probiotic treatment for stony coral tissue loss disease. Communications Biology. 6(1). 248–248. 35 indexed citations
13.
Vargas‐Rodriguez, Oscar, Ahmed H. Badran, Kyle Hoffman, et al.. (2021). Bacterial translation machinery for deliberate mistranslation of the genetic code. Proceedings of the National Academy of Sciences. 118(35). 12 indexed citations
14.
Zhang, Yi, et al.. (2021). Structural and biochemical studies of an iterative ribosomal peptide macrocyclase. Proteins Structure Function and Bioinformatics. 90(3). 670–679. 4 indexed citations
15.
Zhang, Peilan, et al.. (2020). Cyanobacterial Dihydroxyacid Dehydratases Are a Promising Growth Inhibition Target. ACS Chemical Biology. 15(8). 2281–2288. 16 indexed citations
16.
Zhang, Yucheng, Guangde Jiang, Yousong Ding, & Rosemary Loria. (2018). Genetic background affects pathogenicity island function and pathogen emergence in Streptomyces. Molecular Plant Pathology. 19(7). 1733–1741. 18 indexed citations
17.
Zhang, Yi, et al.. (2018). A distributive peptide cyclase processes multiple microviridin core peptides within a single polypeptide substrate. Nature Communications. 9(1). 1780–1780. 32 indexed citations
18.
Zuo, Ran, Aaron T. Garrison, Akash Basak, et al.. (2016). In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans. International Journal of Antimicrobial Agents. 48(2). 208–211. 19 indexed citations
19.
Li, Kunhua, et al.. (2016). Structural basis for precursor protein–directed ribosomal peptide macrocyclization. Nature Chemical Biology. 12(11). 973–979. 50 indexed citations
20.
Yang, Guang & Yousong Ding. (2014). Recent advances in biocatalyst discovery, development and applications. Bioorganic & Medicinal Chemistry. 22(20). 5604–5612. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026